Drug Dose Delivery

Less than 1 min 06/05/21
Author name: John Ross

Drug dose delivery development, manufacturing and commercialization trends: part II

In Part II of Manufacturing Chemist’s roundtable on drug dose delivery, development, manufacturing and commercialization trends, John Ross, President of Metrics Contract Services and Mayne Pharma US, explains how drug delivery technologies have adapted to better serve patient needs. “Multiparticulate (MP) dosage forms are increasingly favoured because of benefits such as predictable gastric emptying, a reduced risk of dose dumping, flexible release patterns and increased bioavailability with less inter- and intra-subject variability.” Read the full article here.


Related Content